P656: NOVEL THIAZOLIDINEDIONE WITH HDAC INHIBITING PROPERTIES OPTIMIZED FOR CHRONIC MYELOID LEUKEMIA TREATMENT

Autor: Anna Rams, Paulina Laskowska, Adrianna Cieloch, Kalpana Tilekar, Neha Upadhyay, C.S. Ramaa, Piotr Mrowka, Eliza Głodkowska-Mrówka

Publikováno v: HemaSphere, Vol 7, p e4945260 (2023)

Externí odkaz: https://doaj.org/article/593fa45c02ef4c0e9c1daba0e8f40bb8

Genetic Association between TNFA Polymorphisms (rs1799964 and rs361525) and Susceptibility to Cancer in Systemic Sclerosis

Autor: Joanna Kosałka-Węgiel, Sabina Lichołai, Sylwia Dziedzina, Mamert Milewski, Piotr Kuszmiersz, Anna Rams, Jolanta Gąsior, Aleksandra Matyja-Bednarczyk, Helena Kwiatkowska, Mariusz Korkosz, Andżelika Siwiec, Paweł Koźlik, Agnieszka Padjas, Wojciech Sydor, Jerzy Dropiński, Marek Sanak, Jacek Musiał, Stanisława Bazan-Socha

Publikováno v: Life, Vol 12, Iss 5, p 698 (2022)

Tumor necrosis factor (TNF)-α is a proinflammatory cytokine that plays an important role in the pathogenesis of autoimmune diseases. The aim of the study was to establish an association between TNF-α promoter variability and systemic sclerosis (SSc

Externí odkaz: https://doaj.org/article/75b81025f0b645debf3a645741c84189

Endothelial dysfunction in patients with systemic sclerosis

Autor: Jacek Musiał, Anna Rams, Stan Kielczewski, Jerzy A. Walocha, Renata Pacholczak-Madej, Joanna Kosałka-Węgiel, Piotr Kuszmiersz, Stanisława Bazan-Socha, Jerzy Dropiński, Teresa Iwaniec, Lech Zareba

Publikováno v: Advances in Dermatology and Allergology, Vol 37, Iss 4, Pp 495-502 (2020)
Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii

Introduction Patients with systemic sclerosis experience endothelial dysfunction and damage even in the absence of clinical manifestations. Aim To evaluate various methods for assessing the endothelial function for their applicability to clinical pra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1141317d5225902aa2f1bf8cf77fa1a
https://www.termedia.pl/Endothelial-dysfunction-in-patients-with-systemic-sclerosis,7,36026,1,1.html

Autoimmune polyendocrine syndrome type 2 in patient with severe allergic asthma treated with omalizumab

Autor: Anna Rams, Weronika Zastrzeżyńska, Agnieszka Serafin, Joanna Wilańska, Stanisław Polański, Stanisława Bazan-Socha, Marek Żółciński, Jacek Musiał

Publikováno v: Journal of Asthma. 55:1384-1386

Asthma therapy with monoclonal antibodies is a promising and effective approach for those with a severe and refractory type of disease. Although such a targeted therapy is considered to be safe, unusual complications may occur. We present a case of a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3874bf86ef006609b9fc9f001e6dfaf5
https://doi.org/10.1080/02770903.2017.1414239

Genetic Association between TNFA Polymorphisms (rs1799964 and rs361525) and Susceptibility to Cancer in Systemic Sclerosis.

Autor: Kosałka-Węgiel, Joanna^1,2,3 (AUTHOR) joanna.kosalka@uj.edu.pl, Lichołai, Sabina¹ (AUTHOR) sylwiaz49@poczta.fm, Dziedzina, Sylwia¹ (AUTHOR) mamert.mmm@gmail.com, Milewski, Mamert^1,4 (AUTHOR) piotrkusz@gmail.com, Kuszmiersz, Piotr^1,2 (AUTHOR) a.m.w.rams@gmail.com, Rams, Anna¹ (AUTHOR) jgasiorr@gmail.com, Gąsior, Jolanta¹ (AUTHOR) aleksandra.matyja-bednarczyk@uj.edu.pl, Matyja-Bednarczyk, Aleksandra^1,4 (AUTHOR) lek.andzelika.siwiec@gmail.com, Kwiatkowska, Helena⁵ (AUTHOR) hkwiatkowska7@gmail.com, Korkosz, Mariusz^2,3 (AUTHOR), Siwiec, Andżelika^1,2 (AUTHOR) pawelkozlik89@gmail.com, Koźlik, Paweł^1,6 (AUTHOR) agnieszka.padjas@uj.edu.pl, Padjas, Agnieszka^1,4 (AUTHOR) wjsydor@gmail.com, Sydor, Wojciech^1,2 (AUTHOR) jerzy.dropinski@uj.edu.pl, Dropiński, Jerzy^1,4 (AUTHOR) marek.sanak@uj.edu.pl, Sanak, Marek¹ (AUTHOR) jacek.musial@uj.edu.pl, Musiał, Jacek^1,4 (AUTHOR) stanislawa.bazan-socha@uj.edu.pl, Bazan-Socha, Stanisława^1,4 (AUTHOR)

Publikováno v: Life (2075-1729). May2022, Vol. 12 Issue 5, p698-698. 10p.